// App-Quantinova.ai

419 : Validation of Clinical Criteria for Progressive Fibrosing Interstitial Lung Disease

Researchers

Presenter

  • J. V. Pugashetti

Principal Investigators

  • A. O. Adegunsoye

  • Z. Wu

  • C. T. Lee

  • A. Srikrishnan

  • S. Ghodrati

  • C. K. Garcia

  • F. Chua

  • C. Newton

  • P. L. Molyneaux

  • J. M. Oldham

Medical Centers

  • University of California at Davis, Sacramento, CA, United States

  • Imperial College London, London, United Kingdom

  • Columbia University, New York, NY, United States

  • University of Chicago, Chicago, IL, United States

  • UT Southwestern Medical Center, Dallas, TX, United States

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic interstitial pneumonias

  • Extrinsic allergic alveolitis

  • Interstitial lung disease

  • Pulmonary alveolar proteinosis

  • Pneumonia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenter

  • Cohort

  • Retrospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved